Ignite Creation Date:
2024-05-06 @ 6:03 PM
Last Modification Date:
2024-10-26 @ 2:40 PM
Study NCT ID:
NCT05520567
Status:
RECRUITING
Last Update Posted:
2024-05-23
First Post:
2022-08-26
Brief Title:
A Study of Gilteritinib Venetoclax and Azacitidine as a Combined Treatment for People Newly Diagnosed With Acute Myeloid Leukemia
Sponsor:
Astellas Pharma Global Development Inc
Organization:
Astellas Pharma Inc
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-01-27
Start Date Type:
ACTUAL
Primary Completion Date:
2028-07-31
Primary Completion Date Type:
ESTIMATED
Completion Date:
2028-07-31
Completion Date Type:
ESTIMATED
First Submit Date:
2022-08-26
First Submit QC Date:
August 26 2022
Study First Post Date:
2022-08-30
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-10-11
Last Update Post Date:
2024-05-23
Last Update Post Date Type:
ACTUAL